FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2010328305> ?p ?o ?g. }

• W2010328305 endingPage "3034" @default.
• W2010328305 startingPage "3026" @default.
• W2010328305 abstract "Regular booster vaccination might be necessary throughout life to protect against pertussis infection. Nevertheless the duration of protection after booster vaccination remains unclear. In this study, antibody persistence up to 10 years after previous vaccination of adolescents (N = 478) with combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine (dTpa, Boostrix™, GlaxoSmithKline Belgium) containing 0.5 mg, 0.3 mg or 0.133 mg of aluminium was assessed. The immunogenicity, reactogenicity and safety of a decennial booster dTpa dose were also investigated. Young adults vaccinated as adolescents in the initial booster study were invited to participate in an assessment of antibody persistence at years 8.5 and 10, and to receive a dTpa booster dose at year 10 with immunogenicity assessment one month later. Those who originally received the 0.5 mg or 0.3 mg formulations received the same vaccine at year 10. Those in the 0.133 mg group received the 0.5 mg formulation. Reactogenicity and safety endpoints were captured until 30 days after booster vaccination. Prior to the decennial booster at year 8.5 and year 10, all participants had seroprotective antibodies for diphtheria (ELISA or neutralisation assay) and tetanus. At least 77.8% were seropositive for anti-pertussis toxin (PT) antibodies at year 8.5 and 82.8% at year 10. All participants were seropositive for antibodies for filamentous haemagglutinin and pertactin at both time points. The decennial booster dose induced robust increases in antibody GMCs to all antigens. The post-booster anti-PT geometric mean concentration was 82.5 EL.U/ml (95%CI 67.0–101.6) and 124.0 (103.5–148.5) in the 0.3 mg and 0.5 mg groups, respectively. The reactogenicity and safety profile of the decennial booster dose was consistent with the known safety profile of dTpa. No serious adverse events were reported. Decennial booster vaccination with either of the two licensed formulations of dTpa was highly immunogenic and well tolerated in young adults. Either formulation could be confidently used as a decennial booster. This study is registered at www.clinicaltrials.gov NCT01147900" @default.
• W2010328305 created "2016-06-24" @default.
• W2010328305 creator A5004494831 @default.
• W2010328305 creator A5011600682 @default.
• W2010328305 creator A5035204811 @default.
• W2010328305 creator A5038401549 @default.
• W2010328305 creator A5045322447 @default.
• W2010328305 creator A5052717145 @default.
• W2010328305 creator A5058655705 @default.
• W2010328305 creator A5085151695 @default.
• W2010328305 date "2015-06-01" @default.
• W2010328305 modified "2023-09-23" @default.
• W2010328305 title "Decennial administration in young adults of a reduced-antigen content diphtheria, tetanus, acellular pertussis vaccine containing two different concentrations of aluminium" @default.
• W2010328305 cites W122113580 @default.
• W2010328305 cites W171480380 @default.
• W2010328305 cites W1893253902 @default.
• W2010328305 cites W1967771379 @default.
• W2010328305 cites W1970924889 @default.
• W2010328305 cites W1986369539 @default.
• W2010328305 cites W1987671699 @default.
• W2010328305 cites W1996297484 @default.
• W2010328305 cites W2007322027 @default.
• W2010328305 cites W2007460782 @default.
• W2010328305 cites W2019415963 @default.
• W2010328305 cites W2026386002 @default.
• W2010328305 cites W2027278839 @default.
• W2010328305 cites W2027431547 @default.
• W2010328305 cites W2028116802 @default.
• W2010328305 cites W2036897121 @default.
• W2010328305 cites W2045006950 @default.
• W2010328305 cites W2052539517 @default.
• W2010328305 cites W2059567873 @default.
• W2010328305 cites W2064627820 @default.
• W2010328305 cites W2076916434 @default.
• W2010328305 cites W2097594720 @default.
• W2010328305 cites W2098217871 @default.
• W2010328305 cites W2106508199 @default.
• W2010328305 cites W2112240708 @default.
• W2010328305 cites W2114175013 @default.
• W2010328305 cites W2131392937 @default.
• W2010328305 cites W2135356371 @default.
• W2010328305 cites W2138640418 @default.
• W2010328305 cites W2152139919 @default.
• W2010328305 cites W2161505461 @default.
• W2010328305 doi "https://doi.org/10.1016/j.vaccine.2014.10.049" @default.
• W2010328305 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25613716" @default.
• W2010328305 hasPublicationYear "2015" @default.
• W2010328305 type Work @default.
• W2010328305 sameAs 2010328305 @default.
• W2010328305 citedByCount "7" @default.
• W2010328305 countsByYear W20103283052015 @default.
• W2010328305 countsByYear W20103283052016 @default.
• W2010328305 countsByYear W20103283052017 @default.
• W2010328305 countsByYear W20103283052018 @default.
• W2010328305 countsByYear W20103283052023 @default.
• W2010328305 crossrefType "journal-article" @default.
• W2010328305 hasAuthorship W2010328305A5004494831 @default.
• W2010328305 hasAuthorship W2010328305A5011600682 @default.
• W2010328305 hasAuthorship W2010328305A5035204811 @default.
• W2010328305 hasAuthorship W2010328305A5038401549 @default.
• W2010328305 hasAuthorship W2010328305A5045322447 @default.
• W2010328305 hasAuthorship W2010328305A5052717145 @default.
• W2010328305 hasAuthorship W2010328305A5058655705 @default.
• W2010328305 hasAuthorship W2010328305A5085151695 @default.
• W2010328305 hasBestOaLocation W20103283051 @default.
• W2010328305 hasConcept C121332964 @default.
• W2010328305 hasConcept C12590561 @default.
• W2010328305 hasConcept C126322002 @default.
• W2010328305 hasConcept C1276947 @default.
• W2010328305 hasConcept C159654299 @default.
• W2010328305 hasConcept C170493617 @default.
• W2010328305 hasConcept C196419574 @default.
• W2010328305 hasConcept C203014093 @default.
• W2010328305 hasConcept C203165030 @default.
• W2010328305 hasConcept C22070199 @default.
• W2010328305 hasConcept C2777704310 @default.
• W2010328305 hasConcept C2779214499 @default.
• W2010328305 hasConcept C2779841045 @default.
• W2010328305 hasConcept C2780572238 @default.
• W2010328305 hasConcept C2780801004 @default.
• W2010328305 hasConcept C2780868878 @default.
• W2010328305 hasConcept C49773422 @default.
• W2010328305 hasConcept C71924100 @default.
• W2010328305 hasConcept C80631254 @default.
• W2010328305 hasConceptScore W2010328305C121332964 @default.
• W2010328305 hasConceptScore W2010328305C12590561 @default.
• W2010328305 hasConceptScore W2010328305C126322002 @default.
• W2010328305 hasConceptScore W2010328305C1276947 @default.
• W2010328305 hasConceptScore W2010328305C159654299 @default.
• W2010328305 hasConceptScore W2010328305C170493617 @default.
• W2010328305 hasConceptScore W2010328305C196419574 @default.
• W2010328305 hasConceptScore W2010328305C203014093 @default.
• W2010328305 hasConceptScore W2010328305C203165030 @default.
• W2010328305 hasConceptScore W2010328305C22070199 @default.
• W2010328305 hasConceptScore W2010328305C2777704310 @default.
• W2010328305 hasConceptScore W2010328305C2779214499 @default.
• W2010328305 hasConceptScore W2010328305C2779841045 @default.
• W2010328305 hasConceptScore W2010328305C2780572238 @default.

• next